Migraine is a potential risk factor for the development of traumatic brain injury (TBI) and is associated with a 78% increased risk for TBI compared with individuals without migraine.
Researchers analyzed the efficacy of interdisciplinary multimodal integrated care in patients with chronic migraine and/or tension-type headache.
Researchers evaluated survey results to determine the prevalence and impact of perceived bullying during residency.
In Iran, researchers found data that showed in a pediatric population of patients with migraine, participants experienced less migraines, while taking levetiracetam, and none of the reported adverse events were significant.
In Korea, researchers found what they believe is a biomarker for migraine, due to evidence of lower fractional plasma volume in the left amygdala from a small cohort.
Women with frequent episodic tension-type headache may have widespread pressure pain hypersensitivity in musculoskeletal structures and over nerve trunks.
In a small cohort, researchers observed that compared with patients having a diagnosis of ordinary migraine, patients diagnosed with sporadic hemiplegic migraine had significantly more white matter hyperintensities in the parietal lobe.
Evidence-based therapies are available for the acute symptomatic treatment of migraine in children and adolescents, but evidence is lacking for the impact of many treatments for migraine prevention.
Patients with migraine who have more headache-free days experience less work productivity loss and activity impairment and lower healthcare resource use.
Less pronounced clinical and radiologic features in asymptomatic idiopathic intracranial hypertension (IIH) may serve as early indicators for symptomatic IIH in children.